iVeena announces the appointment of Alan Crandall, M.D. to the iVeena Scientific Advisory Board to expand its Glaucoma program

13 April 2016

Alan Crandall, M.D. is considered a world authority in the research and treatment of glaucoma. Dr. Crandall has chaired more than 150 major national and international symposia. He has co-authored two text books and authored more than 200 peer reviewed articles. In addition he has trained 33 Glaucoma Fellows and more than 100 residents. "We are extremely pleased to have Alan as a key member of our Glaucoma development team", said Jerry Simmons, iVeena CEO.